De Novo Pyrimidine Synthesis Inhibition for the Treatment of ARID1A Mutated Ovarian Cancers and Other Solid Tumors
Intron Therapeutics: Targeting the Unique Features of Fungal Metabolism to Build a New Generation of Nontoxic Drugs